What amount sold does IMMUCELL CORP /DE/ report in Form D filings?

The latest linked filings report $3.5M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was IMMUCELL CORP /DE/'s most recent SEC filing?

IMMUCELL CORP /DE/'s most recent Form D filing was on 2016-10-24.

How many investors does IMMUCELL CORP /DE/ have?

The most recent Form D filing lists 19 investor(s).

What type of securities does IMMUCELL CORP /DE/ offer?

IMMUCELL CORP /DE/'s SEC Form D filings indicate equity offerings.

IMMUCELL CORP /DE/

CIK: 0000811641·Pharmaceuticals·PORTLAND, ME·Corporation

Reported Sold

$3,464,370

Total Filings

Identified Offerings

Last Filed

Oct 24, 2016

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Oct 24, 2016Form D — New notice

Reported sold: $3,464,370 · Target: Indefinite

Rule 506(b)·19 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$5,000,001 - $25,000,000

Reported commissions across identified offerings

$207,862

Amendment Rate

Latest reported sold across 1 identified offering

$3,464,370

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

MICHAEL F BRIGHAM

Related Person

Appears on 1 filing

JOSEPH CRABB

Related Person

Appears on 1 filing

DAVID CUNNINGHAM

Related Person

Appears on 1 filing

JONATHAN ROTHSCHILD

Related Person

Appears on 1 filing

PAUL WAINMAN

Related Person

Appears on 1 filing

DAVID TOMSCHE

Related Person

Appears on 1 filing

BOBBI BROCKMANN

Related Person

Appears on 1 filing

ELIZABETH WILLIAMS

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 24, 2016	New	Indefinite	$3,464,370	19

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026